Y, K., & C, X. (2018). Transferrin receptor-targeted HMSN for sorafenib delivery in refractory differentiated thyroid cancer therapy. Dove Medical Press.
Chicago Style (17th ed.) CitationY, Ke, and Xiang C. Transferrin Receptor-targeted HMSN for Sorafenib Delivery in Refractory Differentiated Thyroid Cancer Therapy. Dove Medical Press, 2018.
MLA (8th ed.) CitationY, Ke, and Xiang C. Transferrin Receptor-targeted HMSN for Sorafenib Delivery in Refractory Differentiated Thyroid Cancer Therapy. Dove Medical Press, 2018.
Warning: These citations may not always be 100% accurate.